American Vanguard Corporation (AVD) is a Newport Beach, California-based developer and marketer of specialty and agricultural chemicals — crop-protection products, soil insecticides, fungicides, growth regulators, and turf-and-ornamental lines sold largely through distributors in the U.S., Latin America and Australia. The stock traded at $0.785 shortly after Tuesday's opening bell, a gain of 3.09% from Monday's close of $0.7615, confirming an upward move. No verified news catalyst was found for the session. The advance follows a 13.07% decline in the prior session that left the shares at their lowest level in more than a year, and it comes against the backdrop of a company still absorbing a heavily discounted third-quarter report and reduced 2026 outlook.
No verified news or fundamental catalyst found for today's gain. No press release, regulatory filing, analyst rating change or corporate announcement preceded the move, and trading volume has been light in the opening stretch of the session. The most defensible reading of the tape is that the bounce is a technical response to Monday's collapse: the stock fell more than 13% to close at its 52-week low of $0.7615, a level that often invites short-term buying and profit-taking on bearish positions. The pattern is consistent with speculative trading in a micro-cap: shares have moved by 3% or more on 27 of the past 68 sessions, and the average absolute daily move over that stretch is roughly 3.6%. A single modest order can shift the price materially at this market capitalization, near $23 million.
The rebound does not erase the fundamental backdrop. On Nov. 9 the company reported third-quarter net sales of $108.4 million, down 9% year over year and well below the roughly $130 million analysts had expected, with a diluted loss of $0.61 per share against a consensus forecast of about breakeven. Gross margin contracted to 24.2% from 28.7%, adjusted EBITDA fell to break-even from $8.3 million, and net interest expense nearly doubled to $9.1 million. Management cut full-year revenue guidance to $500 million–$530 million and adjusted EBITDA guidance to $36 million–$40 million. International sales dropped 17% on El Niño-related weather disruption and generic competition in Mexico, while diesel costs rose more than 40% in the quarter. Shares fell 15% the following session and another 13% on Monday, extending a decline that has erased more than four-fifths of the company's value in a year.
Volume has not signaled conviction in either direction. Monday's session traded about 401,000 shares, broadly in line with a recent average near 380,000, and Tuesday's early turnover was thin. No sector-wide catalyst was identified: the move appears company-specific rather than part of a broad agricultural-chemicals rotation. Technically, the shares remain below their short- and long-term moving averages, having lost more than two-thirds of their value since mid-August, and they have traded under $1 since early November — a level that puts the stock within reach of the NYSE's minimum price continued-listing standard if it persists. Resistance sits near the $0.87 level that capped Monday's intraday rebound.
On a scale where 0 means no meaningful news and a move that is normal for the stock, and 100 means transformative news paired with an extreme, rare price move, the score is 8 out of 100. No verified news accompanied today's session, so the news component is negligible. The price component is equally muted: the 3.09% advance was about 0.87 times the stock's typical daily move of roughly 3.6%, and a move of that size or larger has occurred 27 times in the last 68 sessions. An ordinary bounce in an unusually volatile micro-cap, without a catalyst, produces a low score.
Attention turns to the fourth quarter, historically the company's strongest period. Management has guided to roughly $166 million in sales, up 10%, and about $21 million in adjusted EBITDA, a target that would exceed the $16.8 million generated across the first nine months combined. That forecast depends on U.S. herbicide and soil-insecticide volumes, a better international result, the Duro LQ corn insecticide launch and $15 million–$20 million of annualized revenue from four Syngenta brands and a Sipcam Agro distribution deal. The key risk is the balance sheet: gross leverage stood at 6.5 times against a 6.7 times first-lien covenant ceiling, leaving limited room for a shortfall, and the company expects about $45 million of fourth-quarter prepayments versus roughly $55 million a year earlier. Diesel and raw-material costs, Latin American weather, and the sustainability of the quarterly dividend are the other variables investors are tracking. Fourth-quarter and full-year results are expected in the first quarter of 2027.
Tickeron's Trending AI Robots page highlights a curated selection from the platform's hundreds of AI trading bots, which collectively cover thousands of tickers. Rather than listing the full catalog, the page surfaces only the bots posting the strongest results under present market conditions. Strategies differ by timeframe, traded symbols and performance metrics, so the leaders rotate as volatility and leadership shift. Reviewing the current list is a practical way to see which approaches are working now — visit the page to explore the active lineup.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for AVD just turned positive on October 28, 2026. Looking at past instances where AVD's MACD turned positive, the stock continued to rise in 34 of 47 cases over the following month. The odds of a continued upward trend are 72%.
Following a +10.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVD advanced for three days, in 187 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
AVD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVD as a result. In 72 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AVD entered a downward trend on November 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.157) is normal, around the industry mean (-0.492). P/E Ratio (-0.504) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (0.867). Dividend Yield (0.125) settles around the average of (0.113) among similar stocks. AVD's P/S Ratio (0.119) is slightly lower than the industry average of (1.476).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. AVD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of a diverse group of agricultural products
Industry ChemicalsAgricultural